HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Innovative Nanowafer Enhances Ocular Therapeutic Efficacy

By HospiMedica International staff writers
Posted on 18 Feb 2015
Print article
Image: The axitinib nanowafer (Photo courtesy of Baylor College of Medicine).
Image: The axitinib nanowafer (Photo courtesy of Baylor College of Medicine).
A new study describes a drug-releasing wafer that works better than a medicine dropper for eye injuries, and could help patients recover faster.

Developed by researchers at Baylor College of Medicine (BCM; Houston, TX, USA), the nanowafer is a small, transparent circular disc made of a non-toxic polymer that is similar to a contact lens. The disc contains arrays of nanoreservoirs loaded with axitinib embedded throughout. The slowly dissolving nanowafer retards drug release over time, thus increasing drug residence time on the ocular surface and promoting absorption into ocular tissue. At the end of the stipulated period of drug release, the nanowafer dissolves and fades away.

The efficacy of the nanowafer was demonstrated by studying corneal neovascularization (CNV) in a murine ocular burn model. Laser scanning confocal imaging and reverse transcription polymerase chain reaction (RT-PCR) revealed that once a day application of the axitinib nanowafer was twice as effective as that of twice a day delivery of axitinib by topical eye drop therapy. The nanowafer did not affect wound healing and epithelial recovery of the ocular burn induced corneas. The study was published on January 27, 2015, in ACS Nano.

“We found that the nanowafer was much more efficient compared to eye drop treatment. For example, once a day nanowafer treatment has almost twice the efficacy compared to delivering eye drops two times a day,” said senior author Ghanashyam Acharya, MD, an assistant professor of ophthalmology at BCM. “It slowly dissolves and maintains a high concentration of the drug in the tear film and loads up the tissue to provide better efficacy.”

“Eye drops are very inefficient because they are diluted out by the tears and then rapidly washed away from the eye, so there’s very little time for the medication in the drop to be picked up or absorbed by the tissue, and as a consequence the concentration of it doesn’t achieve a high level,” added coauthor Prof. Stephen Pflugfelder, MD.

Related Links:

Baylor College of Medicine


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Ventilator
TRventi-3D

Print article

Channels

Surgical Techniques

view channel
Image: The multi-sensing device can be implanted into blood vessels to help physicians deliver timely treatment (Photo courtesy of IIT)

Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health

Researchers have embarked on a project to develop a multi-sensing device that can be implanted into blood vessels like peripheral veins or arteries to monitor a range of bodily parameters and overall health status.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more